ArticleGut microbes reports2025
Method of oral delivery affects vitamin C-mediated alleviation of colitis in a mouse model.
Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin C could be a potential candidate for antioxidant therapy in ulcerative colitis (UC) patients, but efficient small intestinal absorption of vitamin C prevents it from reaching the colon, limiting the direct antioxidative effect on inflamed colonic tissue. We applied a colitis mouse model to compare three oral delivery strategies for high-dose vitamin C: dissolved in drinking water, mixed into peanut butter, and in colon-targeted microcontainers administered with peanut butter. Mice were administered dextran sulfate sodium (DSS) to induce UC symptoms. Healthy control and DSS control groups were included. Alleviation of disease symptoms and microbial dysbiosis were assessed to elucidate the effects of encapsulation and stabilization of vitamin C during intestinal transit. Vitamin C in peanut butter, independent of microcontainers, alleviated UC symptoms. Administration in drinking water surprisingly exacerbated symptoms compared to the DSS control group. DSS-treatment caused an increased level of facultative anaerobes in the fecal microbial community that was not affected by vitamin C administration. Vitamin C partially reduces disease activity index in DSS-treated mice, when delivered in peanut butter, likely promoting vitamin C stability. Drinking water delivery did not support vitamin C-related alleviating effects. None of the evaluated delivery strategies affected the DSS-induced changes of the microbial community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.